Sodium iodide symporter and pendrin expression in human thyroid tissues

C. Mian, L. Lacroix, L. Alzieu, M. Nocera, M. Talbot, J. M. Bidart, M. Schlumberger, B. Caillou

    Research output: Contribution to journalArticlepeer-review

    46 Citations (Scopus)

    Abstract

    Thyroid cells synthesize thyroid hormones through a multistep process during which iodide is transported through the basolateral and the apical membranes of thyrocytes. Two genes that participate in these transports and the corresponding proteins, namely sodium iodide symporter (NIS) and pendrin, the product of the Pendred syndrome gene, have recently been characterized. We studied NIS and pendrin expression at the mRNA and protein levels by a quantitative reverse transcription-polymerase chain reaction (RT-PCR) method and by single and double immunostaining in normal and pathological human thyroid tissues. In normal tissue, NIS and pendrin were detected in about 20% and 40%-60% of thyrocytes, respectively. The number of NIS- and pendrin-positive cells was much higher in hyperfunctioning tissue from Graves' disease or toxic adenoma. In hypofunctioning adenomas and carcinomas, the number of NIS- and pendrin-positive cells was low or nonexistent. Three types of follicular cells were observed in positive tissues: NIS-negative/pendrin-negative cells, NIS-positive/pendrin-positive cells, and NIS-negative/pendrin-positive cells. The first two types of cells appear to be resting and active cells, respectively, but the functional status of NIS-negative/pendrin-positive thyrocytes remains to be determined.

    Original languageEnglish
    Pages (from-to)825-830
    Number of pages6
    JournalThyroid
    Volume11
    Issue number9
    DOIs
    Publication statusPublished - 1 Jan 2001

    Cite this